MedPath

rethral suspension using vas deferens for prevention of urine incontinence after robot-assisted laparoscopic prostatectomy (RALP)

Phase 2
Conditions
urine spill
10038365
urine incontinence
10046590
Registration Number
NL-OMON33954
Lead Sponsor
Antoni van Leeuwenhoek Ziekenhuis
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
94
Inclusion Criteria

= localized prostate cancer treated with prostatectomy
= normal preoperative urine continence

Exclusion Criteria

= earlier prostatic surgery such as TURP
= non-dutch speaking men
= inability to understand informed consent

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Urine continence at 3 and 6 months postoperatively assesed using questionnaires<br /><br>and the urine pad test.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Urine retention and bladder/urethra anastomosis stricture formation and urine<br /><br>leakage at cystogram and erectile function recovery.</p><br>
© Copyright 2025. All Rights Reserved by MedPath